Walgreens Boots Alliance Inc (WBA) Stake Lessened by Systematic Financial Management LP

Systematic Financial Management LP cut its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 5.8% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 42,294 shares of the pharmacy operator’s stock after selling 2,619 shares during the period. Systematic Financial Management LP’s holdings in Walgreens Boots Alliance were worth $3,266,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of WBA. Commonwealth Bank of Australia grew its holdings in shares of Walgreens Boots Alliance by 139.5% during the second quarter. Commonwealth Bank of Australia now owns 46,167 shares of the pharmacy operator’s stock valued at $3,614,000 after buying an additional 26,893 shares during the last quarter. IBM Retirement Fund grew its holdings in shares of Walgreens Boots Alliance by 88.1% during the second quarter. IBM Retirement Fund now owns 22,903 shares of the pharmacy operator’s stock valued at $2,004,000 after buying an additional 10,729 shares during the last quarter. Andra AP fonden grew its holdings in shares of Walgreens Boots Alliance by 35.3% during the second quarter. Andra AP fonden now owns 58,300 shares of the pharmacy operator’s stock valued at $4,565,000 after buying an additional 15,200 shares during the last quarter. Schwab Charles Investment Management Inc. grew its holdings in shares of Walgreens Boots Alliance by 5.4% during the second quarter. Schwab Charles Investment Management Inc. now owns 3,019,739 shares of the pharmacy operator’s stock valued at $236,476,000 after buying an additional 154,995 shares during the last quarter. Finally, Birinyi Associates Inc. grew its holdings in shares of Walgreens Boots Alliance by 9.0% during the second quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock valued at $713,000 after buying an additional 750 shares during the last quarter. 61.18% of the stock is currently owned by institutional investors and hedge funds.

In related news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the transaction, the director now owns 16,415 shares in the company, valued at approximately $1,105,878.55. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director John Anthony Lederer purchased 20,000 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, October 26th. The shares were bought at an average price of $67.00 per share, with a total value of $1,340,000.00. Following the transaction, the director now owns 50,000 shares in the company, valued at $3,350,000. The disclosure for this purchase can be found here. Corporate insiders own 14.80% of the company’s stock.

Shares of Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $72.62 on Friday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.59 and a current ratio of 1.07. Walgreens Boots Alliance Inc has a 12 month low of $63.82 and a 12 month high of $88.00. The stock has a market cap of $71,920.00, a PE ratio of 19.21, a PEG ratio of 1.30 and a beta of 1.22.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The business had revenue of $30.15 billion for the quarter, compared to analyst estimates of $29.93 billion. During the same period in the prior year, the company posted $1.07 EPS. The company’s revenue for the quarter was up 5.3% on a year-over-year basis. research analysts predict that Walgreens Boots Alliance Inc will post 5.54 earnings per share for the current year.

Walgreens Boots Alliance declared that its board has authorized a stock repurchase program on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the pharmacy operator to reacquire shares of its stock through open market purchases. Stock buyback programs are often an indication that the company’s leadership believes its shares are undervalued.

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 12th. Stockholders of record on Monday, November 13th were paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 2.20%. The ex-dividend date of this dividend was Friday, November 10th. Walgreens Boots Alliance’s payout ratio is currently 42.33%.

A number of equities research analysts have recently weighed in on WBA shares. Needham & Company LLC reissued a “buy” rating and set a $94.00 price objective on shares of Walgreens Boots Alliance in a report on Sunday, September 10th. Jefferies Group reissued a “buy” rating and set a $95.00 price objective on shares of Walgreens Boots Alliance in a report on Thursday, September 7th. Mizuho set a $94.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a report on Tuesday, October 24th. Royal Bank of Canada reissued a “buy” rating and set a $88.00 price objective on shares of Walgreens Boots Alliance in a report on Wednesday, October 25th. Finally, Loop Capital set a $90.00 price objective on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a report on Thursday, October 26th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $86.60.

ILLEGAL ACTIVITY NOTICE: This report was first published by Community Financial News and is the property of of Community Financial News. If you are accessing this report on another domain, it was illegally copied and republished in violation of US and international trademark & copyright legislation. The correct version of this report can be viewed at https://www.com-unik.info/2017/12/31/walgreens-boots-alliance-inc-wba-stake-lessened-by-systematic-financial-management-lp.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

What are top analysts saying about Walgreens Boots Alliance? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Walgreens Boots Alliance and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit